CMU-founded road surface analytics technology creator RoadBotics has now raised at least $11.4m, having signed up Radical Ventures and Hyperplane VC to its series A.

The Ontario government has ended a five-year funding initiative which had led to the launch of university-hosted accelerators including CDL, Velocity and DMZ.

CEO Adam Neumann has divested a total of $700m in shares of SoftBank-backed co-working space provider The We Company to undisclosed buyers.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Professor of chemical engineering François Baneyx will lead CoMotion, marking the latest progression in a career with UW that began in 1992.

Venture capital firm Sierra Ventures has received LP commitments from several undisclosed corporates to reach a $215m close.

GV contributed to a round for MIT-founded small molecule cancer drug spinout Kronos Bio, adding to $18m raised by the latter 14 months ago.

Phreesia has raised more than $167m in proceeds after pricing shares above its range at $18, providing exits to BlueCross BlueShield, Ascension Health and Echo Health Ventures.

Mirum Pharmaceuticals has raised $75m in its initial public offering that had an initial target of $86.3m and provided exits to Novo and Shire.

GlaxoSmithKline, Sanofi and 6 Dimensions Capital have all secured exits as the rare disease treatment developer raised $72m in its initial public offering.